About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protagenic Therapeutics, Inc. - Common Stock (NQ:PTIX)

0.7400 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7400
Bid (Size) 0.4400 (20,000)
Ask (Size) 0.4999 (6,200)
Prev. Close 0.7400
Today's Range 0.7400 - 0.7400
52wk Range 0.7400 - 3.320
Shares Outstanding 1,810,208
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder
From Protagenic Therapeutics, Inc.
Via ACCESS Newswire
News headline image
Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model
From Protagenic Therapeutics, Inc.
Via ACCESS Newswire

Performance

52-Week Range 77.7% below 52-week high
0.7400
0.7452W Low 3.3252W High

Protagenic Therapeutics, Inc. - Common Stock (PTIX) traded between $0.74 and $3.32 over the past 52 weeks and last traded at $0.74, 77.7% below its 52-week high.

Past 12 Months
N/A
N/A
N/A
N/A
N/A
-76.9%
1W  
1M  
3M  
6M  
YTD  
1Y -$2.46

PTIX was -76.9% over the past year.

12 Months vs Market
PTIX
-76.9%
DIA
+12.2%
SPY
+14.7%
QQQ
+17.9%
IWM
+8.0%

Over the past 12 months PTIX returned -76.9% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +8.0%.

Volume & Liquidity
1Y
80.4K

More News

Read More
News headline image
Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner
Via ACCESS Newswire
News headline image
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
Via ACCESS Newswire
News headline image
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
Via ACCESS Newswire
News headline image
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
Via ACCESS Newswire
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Results from Phase 1 Multiple-Dose Study of PT00114
Via ACCESS Newswire
News headline image
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
Via ACCESS Newswire
News headline image
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress ↗
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
These stocks are making the most noise in today's session. ↗
Via Chartmill
News headline image
S&P 500 Moves Lower; Walmart Shares Fall After Q2 Results ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Dow Dips Over 100 Points; US Initial Jobless Claims Increase ↗
Via Benzinga
Topics Stocks
News headline image
These stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
News headline image
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
Via Chartmill

Frequently Asked Questions

Is Protagenic Therapeutics, Inc. - Common Stock publicly traded?
Yes, Protagenic Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Protagenic Therapeutics, Inc. - Common Stock trade on?
Protagenic Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Protagenic Therapeutics, Inc. - Common Stock?
The ticker symbol for Protagenic Therapeutics, Inc. - Common Stock is PTIX on the Nasdaq Stock Market
What is the current price of Protagenic Therapeutics, Inc. - Common Stock?
The current price of Protagenic Therapeutics, Inc. - Common Stock is 0.7400
When was Protagenic Therapeutics, Inc. - Common Stock last traded?
The last trade of Protagenic Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Protagenic Therapeutics, Inc. - Common Stock?
The market capitalization of Protagenic Therapeutics, Inc. - Common Stock is 1.34M
How many shares of Protagenic Therapeutics, Inc. - Common Stock are outstanding?
Protagenic Therapeutics, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.